中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/05 | 3,550 | 3,583 | 3,541 | 3,560 | -33 | -0.9% | 1,005,200 |
| 2022/09/02 | 3,593 | 3,604 | 3,560 | 3,593 | +49 | +1.4% | 2,306,500 |
| 2022/09/01 | 3,560 | 3,579 | 3,535 | 3,544 | -65 | -1.8% | 2,150,200 |
| 2022/08/31 | 3,620 | 3,626 | 3,594 | 3,609 | -49 | -1.3% | 2,698,100 |
| 2022/08/30 | 3,676 | 3,691 | 3,639 | 3,658 | +16 | +0.4% | 1,254,600 |
| 2022/08/29 | 3,615 | 3,653 | 3,615 | 3,642 | -63 | -1.7% | 1,886,300 |
| 2022/08/26 | 3,716 | 3,744 | 3,700 | 3,705 | -18 | -0.5% | 1,280,100 |
| 2022/08/25 | 3,721 | 3,728 | 3,681 | 3,723 | +12 | +0.3% | 1,301,300 |
| 2022/08/24 | 3,733 | 3,740 | 3,706 | 3,711 | -16 | -0.4% | 1,337,200 |
| 2022/08/23 | 3,773 | 3,784 | 3,720 | 3,727 | -93 | -2.4% | 1,754,400 |
| 2022/08/22 | 3,789 | 3,837 | 3,786 | 3,820 | +20 | +0.5% | 1,402,400 |
| 2022/08/19 | 3,839 | 3,857 | 3,797 | 3,800 | -41 | -1.1% | 1,377,000 |
| 2022/08/18 | 3,868 | 3,874 | 3,824 | 3,841 | -38 | -1% | 1,141,500 |
| 2022/08/17 | 3,849 | 3,879 | 3,836 | 3,879 | +14 | +0.4% | 2,095,000 |
| 2022/08/16 | 3,851 | 3,867 | 3,823 | 3,865 | -3 | -0.1% | 1,243,000 |
| 2022/08/15 | 3,885 | 3,890 | 3,853 | 3,868 | +7 | +0.2% | 1,896,500 |
| 2022/08/12 | 3,914 | 3,930 | 3,838 | 3,861 | +77 | +2% | 4,141,800 |
| 2022/08/10 | 3,771 | 3,820 | 3,771 | 3,784 | +1 | ±0% | 1,723,700 |
| 2022/08/09 | 3,808 | 3,842 | 3,775 | 3,783 | +3 | +0.1% | 1,747,900 |
| 2022/08/08 | 3,740 | 3,785 | 3,727 | 3,780 | +10 | +0.3% | 1,361,400 |
| 2022/08/05 | 3,720 | 3,770 | 3,711 | 3,770 | +73 | +2% | 1,911,700 |
| 2022/08/04 | 3,717 | 3,724 | 3,647 | 3,697 | +50 | +1.4% | 2,253,800 |
| 2022/08/03 | 3,647 | 3,666 | 3,616 | 3,647 | +36 | +1% | 2,294,000 |
| 2022/08/02 | 3,750 | 3,770 | 3,610 | 3,611 | -185 | -4.9% | 2,838,400 |
| 2022/08/01 | 3,726 | 3,816 | 3,718 | 3,796 | +62 | +1.7% | 2,847,500 |
| 2022/07/29 | 3,723 | 3,774 | 3,711 | 3,734 | +16 | +0.4% | 3,624,900 |
| 2022/07/28 | 3,742 | 3,742 | 3,632 | 3,718 | +26 | +0.7% | 15,023,400 |
| 2022/07/27 | 3,638 | 3,704 | 3,631 | 3,692 | +97 | +2.7% | 3,660,800 |
| 2022/07/26 | 3,686 | 3,704 | 3,589 | 3,595 | -111 | -3% | 3,428,400 |
| 2022/07/25 | 3,739 | 3,749 | 3,682 | 3,706 | -43 | -1.1% | 2,731,500 |
| 2022/07/22 | 3,728 | 3,834 | 3,668 | 3,749 | -19 | -0.5% | 4,464,300 |
| 2022/07/21 | 3,715 | 3,768 | 3,684 | 3,768 | +36 | +1% | 3,349,300 |
| 2022/07/20 | 3,688 | 3,734 | 3,676 | 3,732 | +89 | +2.4% | 2,700,800 |
| 2022/07/19 | 3,702 | 3,707 | 3,620 | 3,643 | -61 | -1.6% | 2,434,600 |
| 2022/07/15 | 3,690 | 3,733 | 3,683 | 3,704 | +15 | +0.4% | 2,057,200 |
| 2022/07/14 | 3,685 | 3,707 | 3,656 | 3,689 | -32 | -0.9% | 1,825,500 |
| 2022/07/13 | 3,677 | 3,748 | 3,677 | 3,721 | +26 | +0.7% | 1,827,500 |
| 2022/07/12 | 3,703 | 3,743 | 3,680 | 3,695 | -42 | -1.1% | 2,437,400 |
| 2022/07/11 | 3,727 | 3,761 | 3,705 | 3,737 | +80 | +2.2% | 2,512,000 |
| 2022/07/08 | 3,714 | 3,714 | 3,610 | 3,657 | -7 | -0.2% | 4,208,900 |
| 2022/07/07 | 3,632 | 3,675 | 3,602 | 3,664 | +40 | +1.1% | 2,485,700 |
| 2022/07/06 | 3,546 | 3,639 | 3,546 | 3,624 | +53 | +1.5% | 2,598,000 |
| 2022/07/05 | 3,561 | 3,589 | 3,529 | 3,571 | +42 | +1.2% | 1,399,000 |
| 2022/07/04 | 3,516 | 3,570 | 3,511 | 3,529 | +53 | +1.5% | 1,620,600 |
| 2022/07/01 | 3,508 | 3,533 | 3,438 | 3,476 | +6 | +0.2% | 2,828,500 |
| 2022/06/30 | 3,574 | 3,576 | 3,451 | 3,470 | -58 | -1.6% | 3,418,100 |
| 2022/06/29 | 3,535 | 3,545 | 3,506 | 3,528 | -61 | -1.7% | 3,456,000 |
| 2022/06/28 | 3,565 | 3,597 | 3,540 | 3,589 | +13 | +0.4% | 1,853,900 |
| 2022/06/27 | 3,599 | 3,606 | 3,565 | 3,576 | +6 | +0.2% | 1,485,300 |
| 2022/06/24 | 3,526 | 3,585 | 3,515 | 3,570 | +97 | +2.8% | 2,390,500 |
651～
700
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 862,000円 | +1.7% | +5.0% | 2.90% | 34.60倍 | 7.46倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 370,200円 | +6.0% | +4.0% | 2.11% | 22.98倍 | 4.25倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 441,900円 | +7.7% | +206.9% | 4.44% | 59.10倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 769,700円 | +2.2% | +10.2% | 1.56% | 14.78倍 | 1.49倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
